Collins: NIH Working Closely With FDA On Next-Generation Sequencing

The National Institutes of Health is working closely with FDA as the government grapples with how to regulate next-generation sequencing, NIH Director Francis Collins told Inside Health Policy on Tuesday (Feb. 9). Collins cited the NIH's ClinGen database -- which aims to curate data provided by professional experts -- as a possible tool for FDA to tap into to investigate the clinical validity of advanced diagnostic tests. “I think what we can do to help here is basically collect...